[{"AccountsPayableCurrent_0_Q2_USD":8343000.0,"OperatingIncomeLoss_2_Q2_USD":-82864000.0,"OperatingLeaseExpense_1_Q2_USD":1200000.0,"OperatingLeaseExpense_2_Q2_USD":2400000.0,"OperatingLeaseLiability_0_Q2_USD":35539000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":2623000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":32916000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":24416000.0,"OtherAssetsNoncurrent_0_Q2_USD":34361000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":-152000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":-614000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2_Q2_USD":-614000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q2_USD":-152000.0,"OtherLiabilitiesCurrent_0_Q2_USD":8869000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":43725000.0,"OtherNoncashIncomeExpense_2_Q2_USD":-1807000.0,"OperatingIncomeLoss_1_Q2_USD":-35315000.0,"NumberOfBusinessesAcquired_2_Q2_business":2.0,"NonoperatingIncomeExpense_2_Q2_USD":-9653000.0,"NonoperatingIncomeExpense_1_Q2_USD":-3648000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":45561000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":6020000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":6578000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":6386000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":6200000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":1842000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":9456000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":216000.0,"Liabilities_0_Q2_USD":414463000.0,"LiabilitiesCurrent_0_Q2_USD":96977000.0,"LiabilitiesFairValueDisclosure_0_Q2_USD":70200000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":196056000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-177513000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-19978000.0,"NetIncomeLoss_1_Q2_USD":-39012000.0,"NetIncomeLoss_2_Q2_USD":-92879000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":746766000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-877000.0,"PaymentForContingentConsiderationLiabilityFinancingActivities_2_Q2_USD":1399000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":406000000.0,"ShareBasedCompensation_2_Q2_USD":14767000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":6200000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":19.23,"StockGrantedDuringPeriodValueSharebasedCompensationGross_1_Q2_USD":319000.0,"StockGrantedDuringPeriodValueSharebasedCompensationGross_2_Q2_USD":3074000.0,"StockholdersEquity_0_Q2_USD":332303000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":1496000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":71743000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_2_Q2_USD":1710000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":-98000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":7288000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_2_Q2_USD":14767000.0,"TemporaryEquityForeignCurrencyTranslationAdjustments_2_Q2_USD":875000.0,"TemporaryEquityForeignCurrencyTranslationAdjustments_1_Q2_USD":-227000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":60571259.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":58431770.0,"StockIssuedDuringPeriodValueNewIssues_2_Q2_USD":194157000.0,"InventoryValuationReserves_0_Q2_USD":3500000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":34965000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":54617000.0,"PaymentsToAcquireIntangibleAssets_2_Q2_USD":8979000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":4598000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"PreferredStockSharesAuthorized_0_Q2_shares":20000000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockValue_0_Q2_USD":0.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":102024000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":7339000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":242064000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":3074000.0,"ProceedsFromStockPlans_2_Q2_USD":1275000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":11720000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":51807000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":99753000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-678754000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_2_Q2_USD":242100000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":4099000.0,"InventoryNet_0_Q2_USD":7409000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":3310000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":328250000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q2_USD":111252000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2_Q2_USD":-3602000.0,"BusinessCombinationContingentConsiderationLiability_0_Q2_USD":70200000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":83288000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":83288000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-1484000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":439502000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"CommonStockSharesIssued_0_Q2_shares":60710876.0,"CommonStockSharesOutstanding_0_Q2_shares":60710876.0,"CommonStockValue_0_Q2_USD":6000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-39391000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-92618000.0,"ConvertibleDebtFairValueDisclosures_0_Q2_USD":234700000.0,"ConvertibleDebtNoncurrent_0_Q2_USD":220861000.0,"CommonStockSharesAuthorized_0_Q2_shares":200000000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":1651000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":439411000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":221000.0,"AccountsReceivableNetCurrent_0_Q2_USD":11860000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-660000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":62465000.0,"AccruedSalariesCurrent_0_Q2_USD":12656000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-641000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":1011692000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":7510000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":130000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":15204000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":6136000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":12088000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":18072393.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":18026005000.0,"Assets_0_Q2_USD":746766000.0,"AssetsCurrent_0_Q2_USD":549798000.0,"AssetsFairValueDisclosure_0_Q2_USD":522790000.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":5522000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":58431770.0,"CostOfGoodsAndServicesSold_2_Q2_USD":3296000.0,"CostsAndExpenses_2_Q2_USD":184888000.0,"IncentiveToLessee_0_Q2_USD":566000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-38963000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-92517000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":49000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":362000.0,"IncomeTaxReceivable_0_Q2_USD":400000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":4681000.0,"Goodwill_0_Q2_USD":936000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-4056000.0,"IncreaseDecreaseInInventories_2_Q2_USD":764000.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":1224000.0,"IncreaseDecreaseInOtherOperatingLiabilities_2_Q2_USD":-453000.0,"InterestIncomeExpenseNet_1_Q2_USD":988000.0,"InterestIncomeExpenseNet_2_Q2_USD":1397000.0,"InterestIncomeExpenseNonoperatingNet_1_Q2_USD":-4852000.0,"InterestIncomeExpenseNonoperatingNet_2_Q2_USD":-10173000.0,"IncreaseDecreaseInIncomeTaxesReceivable_2_Q2_USD":-17011000.0,"CostsAndExpenses_1_Q2_USD":89932000.0,"ForeignCurrencyTransactionGainLossRealized_2_Q2_USD":875000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":149951000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q2_USD":0.0,"DebtSecuritiesAvailableForSaleAmortizedCostCurrent_0_Q2_USD":439411000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_0_Q2_USD":0.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_0_Q2_USD":0.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q2_USD":282594000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0_Q2_USD":130000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q2_USD":282594000.0,"ForeignCurrencyTransactionGainLossRealized_1_Q2_USD":-227000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_0_Q2_USD":130000.0,"EarningsPerShareBasic_2_Q2_USD":-1.59,"EarningsPerShareBasic_1_Q2_USD":-0.64,"EarningsPerShareDiluted_1_Q2_USD":-0.64,"EarningsPerShareDiluted_2_Q2_USD":-1.59,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-49000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":123381000.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":273332000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":12694000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":60571259.0,"Ticker":"TVTX","CIK":"1438533","name":"TRAVERE THERAPEUTICS, INC.","OfficialName":"Travere Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1905907401.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210729"}]